👋👋👋Final hour of #ELIXR25 Jeopardy - which team will win? Is it team 🇪🇺or 🇨🇦 or 🇺🇸?

Hilarious. 😂 Should add that if p>0.05 some might change endpoint and re-analyze! This is just unthinkable when in grad school the mere mention of p value will give us negative points in exams!

🚨Advanced Pract Radiation Therapist🚨 🌟 #APRT Joanna Javor of Allan & Ruth Kerbel Pall RT/Oligomet Program (PROP) presented data of sim-free RT (incl single fx #SBRT 12-20Gy). Best wishes for her med school pursuit! 🔥 📢📢PS. We will be looking for an #APRT. PM me for details.

👀Not cancer but promising concept/result. As we expand the indication of #radiotherapy this could be an area of active interest. Sameer Keole ASTRO thelancet.com/journals/lance…

Interesting images for all the HN surgeons! Frostbite Injury from Inhaled Nitrous Oxide Use | New England Journal of Medicine nejm.org/doi/full/10.10…

p-Values and confidence intervals as compatibility measures: guidelines for interpreting statistical studies in clinical research - The Lancet Regional Health - Southeast Asia thelancet.com/journals/lanse…

The PROP (Pall RT & Oligomet Progeam) Princess Margaret Cancer Centre University Health Network would not be successful without our #APRT (previously CSRT). They play a vital role in patient care and clinical trials. Would love to see an expansion of such endeavor. Yat Tsang David Kirsch, MD, PhD Laura Dawson

Congrats Rebecca Wong Radiation Medicine Program Princess Margaret Cancer Centre University Health Network! David Kirsch, MD, PhD Laura Dawson

Interesting paper, although I wouldn't have included CURB since it's not OMD. Also would include LU002. Efficacy and Safety of Metastatic Directed Treatment of Oligometastatic Disease: Results of a Meta-analysis - Advances in Radiation Oncology advancesradonc.org/article/S2452-…

⏰ A critical read about how small changes can have significant consequences. Data manipulation within the US Federal Government - The Lancet thelancet.com/journals/lance…

🎉 Just announced: A huge congrats to #RMPatPM staff Scott Bratman C. Jillian Tsai, MD, PhD Dr. Philip Wong David Kirsch, MD, PhD Marianne Koritzinsky who received over $3.5 million in CIHR funding for their cutting-edge radiation research. See highlights below⤵️

En route to NRG Oncology and will speak with colleagues about updates of CCTG NCICancerTrials #CURB2 trial. This sign at the airport seems fitting! Kristin Higgins Jeff Bradley, MD Radiation Oncology Radiation Medicine Program

Our Collaborative Centre for Clinical Research is leading the IA45 initiative with a goal that all clinical research studies can be activated in 45 days. Good for patients, good for research progress.

On Head and Neck Cancer Day, we’re sharing a list of top trials in #HNC from 2025. 🔗 Follow us for latest clinical trials and insights from the world of oncology 👉 clin.larvol.com #LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights

For Head and Neck Cancer Day, we’re highlighting the top #HNC oncologists with most views on 𝕏 in 2025. 🔗 Follow us for latest clinical trials and insights from the world of oncology 👉 clin.larvol.com #LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData

On Head and Neck Cancer Day, we’re sharing key anticipated milestones expected in 2025. 🔗 Follow us for latest clinical trials and insights from the world of oncology 👉 clin.larvol.com #LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights

To mark Head and Neck Cancer Day, we’ve highlighted drugs in Phase 3 and beyond that are in active development for #HNC. 🔗 Follow us for latest clinical trials and insights from the world of oncology 👉 clin.larvol.com #LARVOL #CancerResearch #Oncology #ClinicalTrials